Skip to content
Prolacta Bioscience logo — Advancing the science of human millk

Prolacta Bioscience

Advancing the science of human millk

Founded 1999 United States City Of Industry, United States 317 employees Total: $78.05M Biotechnology, Health Care +2

General Information

Company Name Prolacta Bioscience
Founded Year 1999
Location United States City Of Industry, United States
Founders / Decision Makers
Team member Team member
Employees 317
Industries Biotechnology, Health Care, Life Sciences +1
Social

BounceWatch is an independent company data service, not affiliated with Prolacta Bioscience. To contact Prolacta Bioscience, visit prolacta.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prolacta Bioscience compare?

A PDF of Prolacta Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prolacta Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prolacta Bioscience

Prolacta Bioscience, founded in 1999, is a pioneer in the biotechnology and life sciences sector, headquartered in the United States. The company’s mission is encapsulated in its slogan: "Advancing the Science of Human Milk.” Prolacta is transforming neonatal care by utilizing human milk-based nutritional products designed specifically for the most vulnerable preemies in hospital neonatal units across the nation.

The company operates within the health care and nutrition industries, dedicating its research and product development to enhancing outcomes for critically ill infants. The last recorded investment in the company was an $8.91M venture round in May 2018. Strategic investors should note Prolacta's commitment to reshaping nutritional standards in neonatal care, positioning it as a leading figure in its niche market.

Business keywords: Prolacta Bioscience, neonatal nutrition, human milk-based products, NICU nutrition, preemies care, neonatal care, life sciences company, infant health, critical care, nutritional products, breast milk research

Services & Products

Human milk fortification for preterm infants
Nutrition solutions for term infants with gastroschisis
Clinical research and evidence-based nutrition solutions
NICU protocol implementation and support

Target Customers

Healthcare professionals NICUs Parents of preterm and critically ill term infants Milk donors Hospitals

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $8.90M -
01 May 2018
Late VC $35.00M 4
EW Healthcare Partners, Aisling Capital +2
01 Dec 2016
Series D $15.00M 1
Health Evolution Partners
01 Nov 2011
Early VC $5.80M 3
Aisling Capital, Health Evolution Partners +1
01 Aug 2011
Series C $12.00M 8
Draper Associates, Mercury Fund +6
01 May 2007
Series B $540.00K 2
Mercury Fund, Funk Ventures
01 Nov 2006
Series A $810.00K -
01 Jun 2004

Prolacta Bioscience Alternatives & Competitors

View All Alternatives
Prolacta Bioscience vs
LactaLogics
LactaLogics United States

Bringing more human milk to babies

Debt Financing
10 employees
Food and Beverage, Health Care
Prolacta Bioscience vs

Human milk-inspired nutrition: the true standard of care for all babies and families (when human mil...

Seed
11 employees
Biotechnology, Food and Beverage
Prolacta Bioscience vs
Helaina
Helaina United States

Human proteins for human nutrition

Series B
51 employees
Biotechnology, Health Care

FAQ About Prolacta Bioscience

Advancing the science of human millk
Prolacta Bioscience was founded in 1999.
Prolacta Bioscience is headquartered in City Of Industry, United States.
Prolacta Bioscience operates in Biotechnology, Health Care, Life Sciences and Nutrition. Its work centres on Prolacta Bioscience, neonatal nutrition, human milk-based products and NICU nutrition. Its customers include Healthcare professionals, NICUs and Parents of preterm and critically ill term infants.
Prolacta Bioscience has approximately 317 employees.
Prolacta Bioscience has completed 7 funding rounds, raising a total of $78.05M.
Prolacta Bioscience offers: Human milk fortification for preterm infants, Nutrition solutions for term infants with gastroschisis, Clinical research and evidence-based nutrition solutions, NICU protocol implementation and support.
Top alternatives and competitors to Prolacta Bioscience include LactaLogics, Harmony Baby Nutrition, Helaina, ByHeart, DSM. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prolacta Bioscience and LactaLogics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prolacta Bioscience, https://www.bouncewatch.com/company/prolacta-bioscience, updated 23 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout